| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Dec 01, 2023 | Buy | $1.31 | 192,960 | 252,778 | 384,757 | Dec 05, 2023, 04:30 PM | |
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Dec 04, 2023 | Buy | $1.50 | 150,000 | 225,000 | 534,757 | Dec 05, 2023, 04:30 PM | |
| VKTX | Viking Therapeutics, Inc. | Rowland Charles A Jr | Director | May 16, 2023 | Sale | $25.00 | 40,000 | 1,000,000 | 30,000 | May 18, 2023, 06:31 PM | |
| VKTX | Viking Therapeutics, Inc. | Rowland Charles A Jr | Director | May 16, 2023 | Option Exercise | $1.08 | 40,000 | 43,200 | 70,000 | May 18, 2023, 06:31 PM | |
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Sep 19, 2022 | Buy | $5.26 | 15,750 | 82,845 | 191,797 | Sep 20, 2022, 04:16 PM | |
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Sep 15, 2022 | Buy | $5.41 | 17,147 | 92,765 | 142,566 | Sep 19, 2022, 05:21 PM | |
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Sep 16, 2022 | Buy | $5.48 | 33,481 | 183,476 | 176,047 | Sep 19, 2022, 05:21 PM | |
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Sep 14, 2022 | Buy | $5.30 | 5,600 | 29,652 | 125,419 | Sep 15, 2022, 04:07 PM | |
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Sep 13, 2022 | Buy | $5.20 | 18,784 | 97,752 | 119,819 | Sep 15, 2022, 04:07 PM | |
| NBRV | Nabriva Therapeutics plc | Rowland Charles A Jr | Director | Aug 01, 2022 | Sale | $0.17 | 8,496 | 1,487 | 15,277 | Aug 03, 2022, 09:48 PM | |
| NBRV | Nabriva Therapeutics plc | Rowland Charles A Jr | Director | Aug 02, 2021 | Sale | $1.20 | 777 | 932 | 23,773 | Aug 04, 2021, 09:05 PM | |
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Jan 11, 2021 | Buy | $24.50 | 20,408 | 499,996 | 101,035 | Jan 13, 2021, 04:04 PM | |
| BPMC | Blueprint Medicines Corp | Rowland Charles A Jr | Director | Dec 17, 2020 | Option Exercise | $19.53 | 10,909 | 213,053 | 14,471 | Dec 18, 2020, 04:09 PM | |
| BPMC | Blueprint Medicines Corp | Rowland Charles A Jr | Director | Dec 17, 2020 | Sale | $117.82 | 10,909 | 1,285,298 | 3,562 | Dec 18, 2020, 04:09 PM | |
| BPMC | Blueprint Medicines Corp | Rowland Charles A Jr | Director | Nov 02, 2020 | Option Exercise | $9.46 | 4,478 | 42,362 | 8,040 | Nov 04, 2020, 05:18 PM | |
| BPMC | Blueprint Medicines Corp | Rowland Charles A Jr | Director | Nov 02, 2020 | Sale | $99.11 | 4,478 | 443,815 | 3,562 | Nov 04, 2020, 05:18 PM | |
| BPMC | Blueprint Medicines Corp | Rowland Charles A Jr | Director | Nov 03, 2020 | Option Exercise | $9.46 | 5,522 | 52,238 | 9,084 | Nov 04, 2020, 05:18 PM | |
| BPMC | Blueprint Medicines Corp | Rowland Charles A Jr | Director | Nov 03, 2020 | Sale | $98.73 | 5,522 | 545,196 | 8,984 | Nov 04, 2020, 05:18 PM | |
| GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Jun 16, 2020 | Buy | $19.00 | 30,000 | 570,000 | 80,627 | Jun 18, 2020, 05:30 PM | |
| BPMC | Blueprint Medicines Corp | Rowland Charles A Jr | Director | Jun 20, 2019 | Option Exercise | $9.46 | 11,818 | 111,798 | 11,818 | Jun 24, 2019, 08:08 PM | |
| BPMC | Blueprint Medicines Corp | Rowland Charles A Jr | Director | Jun 20, 2019 | Sale | $95.15 | 11,818 | 1,124,462 | 10,871 | Jun 24, 2019, 08:08 PM | |
| NBRV | Nabriva Therapeutics plc | Rowland Charles A Jr | Director | Dec 24, 2018 | Buy | $1.31 | 53,000 | 69,430 | 53,000 | Dec 27, 2018, 04:05 PM | |
| VKTX | Viking Therapeutics, Inc. | Rowland Charles A Jr | Director | May 29, 2018 | Buy | $5.16 | 30,000 | 154,800 | 30,000 | May 31, 2018, 07:02 PM | |
| BIND | DNIB UNWIND, INC. | Rowland Charles A Jr | Director | Aug 26, 2016 | Option Exercise | $0.44 | 15,000 | 6,600 | 15,000 | Aug 30, 2016, 04:39 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Jan 24, 2014 | Option Exercise | $50.00 | 87,026 | 4,351,300 | 0 | Jan 28, 2014, 08:35 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Jan 08, 2014 | Option Exercise | $49.80 | 6,449 | 321,160 | 87,026 | Jan 10, 2014, 01:34 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Jan 08, 2014 | Option Exercise | $9.50 | 28,753 | 273,157 | 88,003 | Jan 10, 2014, 01:34 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Dec 27, 2013 | Option Exercise | $49.86 | 704 | 35,101 | 64,722 | Dec 31, 2013, 04:33 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Dec 27, 2013 | Option Exercise | $5.91 | 4,540 | 26,831 | 65,426 | Dec 31, 2013, 04:33 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Dec 18, 2013 | Option Exercise | $9.26 | 49,006 | 453,673 | 72,721 | Dec 20, 2013, 04:13 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Dec 18, 2013 | Option Exercise | $49.74 | 25,129 | 1,249,917 | 60,886 | Dec 20, 2013, 04:13 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Mar 07, 2012 | Option Exercise | $29.49 | 12,715 | 374,965 | 35,048 | Mar 09, 2012, 04:08 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Mar 07, 2012 | Option Exercise | $12.24 | 30,638 | 374,985 | 47,763 | Mar 09, 2012, 04:08 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Mar 01, 2012 | Option Exercise | $9.99 | 70,000 | 699,200 | 99,875 | Mar 05, 2012, 04:01 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Mar 01, 2012 | Sale | $32.12 | 82,750 | 2,657,631 | 29,875 | Mar 05, 2012, 04:01 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Mar 14, 2011 | Option Exercise | $8.02 | 35,000 | 280,600 | 63,496 | Mar 15, 2011, 04:50 PM | |
| VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial Officer | Mar 14, 2011 | Sale | $18.57 | 35,000 | 649,950 | 53,496 | Mar 15, 2011, 04:50 PM |
Menu